State Street Corp Adma Biologics, Inc. Transaction History
State Street Corp
- $2.41 Trillion
- Q3 2024
A detailed history of State Street Corp transactions in Adma Biologics, Inc. stock. As of the latest transaction made, State Street Corp holds 13,004,993 shares of ADMA stock, worth $226 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,004,993
Previous 8,059,930
61.35%
Holding current value
$226 Million
Previous $90.1 Million
188.5%
% of portfolio
0.01%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$325 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$315 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$220 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$150 Million0.01% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL6.58MShares$115 Million0.04% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.42B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...